ID

16702

Beschrijving

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Relapse Report

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Trefwoorden

  1. 01-08-16 01-08-16 -
Geüploaded op

1 augustus 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

Relapse Report
Beschrijving

Relapse Report

Date of Relapse
Beschrijving

Date of Relapse

Datatype

text

Alias
UMLS CUI [1]
C0807712
New Lesion Specification
Beschrijving

New Lesion Specification

Lesion number
Beschrijving

Lesion number

Datatype

integer

Alias
UMLS CUI [1,1]
C0221198
UMLS CUI [1,2]
C0750480
Method of Evaluation
Beschrijving

Provide relevant code number for Method of Evaluation and Disease Site. lf "Other'' applies, use code 99 and specify.

Datatype

integer

Alias
UMLS CUI [1]
C2911685
If other, specify
Beschrijving

Method of Evalution

Datatype

text

Alias
UMLS CUI [1]
C2911685
Disease Site
Beschrijving

Site of Lesion

Datatype

integer

Alias
UMLS CUI [1]
C0449685
If other, specify
Beschrijving

Disease Site

Datatype

text

Alias
UMLS CUI [1]
C0449685
Date of Evaluation
Beschrijving

Date of Evaluation

Datatype

date

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C0031809

Similar models

Relapse Report, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
Relapse Report
Date of Relapse
Item
Date of Relapse
text
C0807712 (UMLS CUI [1])
Item Group
New Lesion Specification
Lesion number
Item
Lesion number
integer
C0221198 (UMLS CUI [1,1])
C0750480 (UMLS CUI [1,2])
Item
Method of Evaluation
integer
C2911685 (UMLS CUI [1])
Code List
Method of Evaluation
CL Item
CT 1  (1)
CL Item
CT Spiral 2  (2)
CL Item
MRI 3 (3)
CL Item
Palpation 4  (4)
CL Item
PET 5  (5)
CL Item
Scintigraphy 6 (6)
CL Item
Ultrasound 7 (7)
CL Item
X-ray 8 (8)
CL Item
Biopsy 9 (9)
CL Item
Other (specify) 99 (10)
Method of Evalution
Item
If other, specify
text
C2911685 (UMLS CUI [1])
Item
Disease Site
integer
C0449685 (UMLS CUI [1])
Code List
Disease Site
CL Item
Abdominal 1 (1)
CL Item
Adrenal 34 (2)
CL Item
Ascites 33 (3)
CL Item
Bile Duct 37 (4)
CL Item
Bladder 2 (5)
CL Item
Bone 3 (6)
CL Item
Bone Marrow 38 (7)
CL Item
Brain 39 (8)
CL Item
Breast 4 (9)
CL Item
Cervix 5 (10)
CL Item
CNS/Spinal 6 (11)
CL Item
Colorectal 7 (12)
CL Item
Esophagus 8 (13)
CL Item
Gallbladder 9 (14)
CL Item
Gastric 10 (15)
CL Item
Gastroesophageal Junction 36 (16)
CL Item
Head & Neck 11 (17)
CL Item
Kidney 12 (18)
CL Item
Liver 13 (19)
CL Item
Lung 14 (20)
CL Item
Mediastinum 15 (21)
CL Item
Omentum 17 (22)
CL Item
Ovary 18 (23)
CL Item
Pacreas 19 (24)
CL Item
Pelvic 20 (25)
CL Item
Penis 21 (26)
CL Item
Pericardium 22 (27)
CL Item
Peripheral Lymph Node 16 (28)
CL Item
Peritoneum 23 (29)
CL Item
Pleura 24 (30)
CL Item
Pleural Effusion 32 (31)
CL Item
Prostate 25 (32)
CL Item
Retroperitoneum 35 (33)
CL Item
Skin 26 (34)
CL Item
Small Intestine 27 (35)
CL Item
Soft Tissue 28 (36)
CL Item
Spleen 29 (37)
CL Item
Testis 30 (38)
CL Item
Uterus 31 (39)
CL Item
Other (specify) 99 (40)
Disease Site
Item
If other, specify
text
C0449685 (UMLS CUI [1])
Date of Evaluation
Item
Date of Evaluation
date
C0011008 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,3])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial